New report states strong economic case for drug reform

New report states strong economic case for drug reform

Wednesday, November 07, 2018

Extra investment in drug treatment, education and harm reduction could benefit NZ economically by $450 million a year, according to a new report.

Commissioned by NZ Needle Exchange Programme (NZNEP), NZ Drug Foundation and Matua Raki, the report estimates there would be a net social benefit of $34m to $83m from replacing the Misuse of Drugs Act with new health-based drug law. The Needle Exchange Programme executive director says harm reduction needed to be part of any treatment model.

Learn More